Another relevant subject of controversy is represented by the pathological classification of these uncommon cases of MNs showing NPM1 gene mutations with <20% circulating and BM blast counts, also with potentially significant implications on the choice of best therapeutic approaches [5,69]. Here, NPM1 is linked to Melnick-Needles syndrome.